Evidence map›Paper›PMID 37470934›Full record

ArticleApplied biochemistry and biotechnology2024

RNA-Seq Analysis Reveals Altered Expression of Cell Adhesion-Related Genes Following PZR Knockout in Lung Cancer Cells.

Ying Fu, Guodong Li, Xueqi Fu, Shu Xing, Zhizhuang Joe Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ying FuEdmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University, Changchun, China.
Guodong LiDepartment of Colorectal and Anal Surgery, the Second Hospital, Jilin University, Changchun, China.
Xueqi FuEdmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University, Changchun, China.
Shu XingEdmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University, Changchun, China. xingshu@jlu.edu.cn.
Zhizhuang Joe ZhaoDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. joe-zhao@ouhsc.edu.

Funding

Jilin Scientific and Technological Development Program 20200201386JCJilin Scientific and Technological Development Program 20210101004JCNational Key Research and Development Program of China 2021YFA1500400
6 · The paper itself

Abstract

Protein zero related (PZR) serves as a substrate and anchor protein for SHP-2, the product of the proto-oncogene PTPN11 that is frequently mutated in cancers. The expression level of PZR is elevated in various cancers, which is correlated with an unfavorable prognosis. The role of PZR in lung cancer is not fully studied. To investigate how PZR affects signaling pathways involved in LUAD development, we utilized the CRISPR technology to knock out PZR expression in SPC-A1 lung adenocarcinoma cells and then conducted RNA sequencing to profile the transcriptome. Our results showed that 226 genes exhibited differential expressions in PZR-knockout SPC-A1 cells vs wild-type cells. Many of the genes encode proteins involved in cell adhesion, migration, actin cytoskeleton organization, and regulation of cell shape. Furthermore, our experimental data showed that PZR-knockout SPC-A1 cells displayed faster attachment to tissue culture dishes and slower detachment from the dishes upon EDTA treatment. The data suggest an important role of PZR in cell-matrix interaction and may provide new insights into the signaling events that regulate cancer development.

Indexed as

Cell AdhesionLung NeoplasmsProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene MasCell Line, TumorGene Expression Regulation, NeoplasticGene Knockout TechniquesHumansRNA-SeqMAS1 protein, humanProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene MasPTPN11 protein, humanCOL1A1FYNLung cancerPZRRNA-seq

Identifiers

PMID37470934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.